# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001892612 (5)

Office of origin: United States of America

Date of International Registration:21 November 2025
Date of designation in the UK: 21 November 2025

International priority date claimed: 22 May 2025 (United States of America) (99197944)

Class 5
  Medicinal preparations for the treatment and prevention of lymphopenia, cancer, and infectious diseases; pharmaceutical preparations for the treatment of lymphopenia, cancer, and infectious diseases; pharmaceutical preparations for the prevention of lymphopenia, cancer, and infectious diseases; biological preparations for the prevention and treatment of lymphopenia, cancer, and infectious diseases; vaccines.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA